Indivior Pharmaceuticals Inc
INDV
Rang in aandelen
#3814
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aandeelprijs
$34.70
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$4.33B
Verandering (1 dag)
-0.20%
Verandering (1 jaar)
39.36%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Categorie
Healthcare
Koersgeschiedenis voor Indivior Pharmaceuticals Inc (INDV)
Hoogste slotkoers: $35.03 op 2026-10-01
Laagste slotkoers: $10.90 op 2014-12-01
Laagste slotkoers: $10.90 op 2014-12-01
Koersgeschiedenis van Indivior Pharmaceuticals Inc van 2014 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -1.35% |
| 2025 | 202.98% |
| 2024 | -23.97% |
| 2023 | -28.64% |
| 2022 | 35.86% |
| 2021 | 132.41% |
| 2020 | 154.62% |
| 2019 | -56.62% |
| 2018 | -76.25% |
| 2017 | 41.62% |
| 2016 | 30.92% |
| 2015 | 29.04% |
| 2014 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $7.02 | -23.31% |
CN
|
